Global Antibody-drug Conjugate Market Research Report 2020

Publisher Name :
Date: 24-Mar-2020
No. of pages: 95
Inquire Before Buying

The global Antibody-drug Conjugate market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.

This report focuses on Antibody-drug Conjugate volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Antibody-drug Conjugate market is segmented into

- Adcetris

- Kadcyla

Segment by Application

- Breast Cancer

- Lymphoma

Global Antibody-drug Conjugate Market: Regional Analysis

The Antibody-drug Conjugate market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Antibody-drug Conjugate market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Antibody-drug Conjugate Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Antibody-drug Conjugate market include:

- Agensys

- Concortis Biotherapeutics

- Sanofi

- Celldex Therapeutics

- Synthon Holding BV

Global Antibody-drug Conjugate Market Research Report 2020

Table of Contents
1 Antibody-drug Conjugate Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugate
1.2 Antibody-drug Conjugate Segment by Type
1.2.1 Global Antibody-drug Conjugate Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugate Segment by Application
1.3.1 Antibody-drug Conjugate Sales Comparison by Application: 2020 VS 2026
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugate Market Size Estimates and Forecasts
1.4.1 Global Antibody-drug Conjugate Revenue 2015-2026
1.4.2 Global Antibody-drug Conjugate Sales 2015-2026
1.4.3 Antibody-drug Conjugate Market Size by Region: 2020 Versus 2026
2 Global Antibody-drug Conjugate Market Competition by Manufacturers
2.1 Global Antibody-drug Conjugate Sales Market Share by Manufacturers (2015-2020)
2.2 Global Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
2.3 Global Antibody-drug Conjugate Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Antibody-drug Conjugate Manufacturing Sites, Area Served, Product Type
2.5 Antibody-drug Conjugate Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugate Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Antibody-drug Conjugate Players (Opinion Leaders)
3 Antibody-drug Conjugate Retrospective Market Scenario by Region
3.1 Global Antibody-drug Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Antibody-drug Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Antibody-drug Conjugate Market Facts & Figures by Country
3.3.1 North America Antibody-drug Conjugate Sales by Country
3.3.2 North America Antibody-drug Conjugate Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody-drug Conjugate Market Facts & Figures by Country
3.4.1 Europe Antibody-drug Conjugate Sales by Country
3.4.2 Europe Antibody-drug Conjugate Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody-drug Conjugate Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody-drug Conjugate Sales by Region
3.5.2 Asia Pacific Antibody-drug Conjugate Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody-drug Conjugate Market Facts & Figures by Country
3.6.1 Latin America Antibody-drug Conjugate Sales by Country
3.6.2 Latin America Antibody-drug Conjugate Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Antibody-drug Conjugate Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody-drug Conjugate Sales by Country
3.7.2 Middle East and Africa Antibody-drug Conjugate Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibody-drug Conjugate Historic Market Analysis by Type
4.1 Global Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
4.2 Global Antibody-drug Conjugate Revenue Market Share by Type (2015-2020)
4.3 Global Antibody-drug Conjugate Price Market Share by Type (2015-2020)
4.4 Global Antibody-drug Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Antibody-drug Conjugate Historic Market Analysis by Application
5.1 Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
5.2 Global Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
5.3 Global Antibody-drug Conjugate Price by Application (2015-2020)
6 Company Profiles and Key Figures in Antibody-drug Conjugate Business
6.1 Agensys
6.1.1 Corporation Information
6.1.2 Agensys Description, Business Overview and Total Revenue
6.1.3 Agensys Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Agensys Products Offered
6.1.5 Agensys Recent Development
6.2 Concortis Biotherapeutics
6.2.1 Concortis Biotherapeutics Antibody-drug Conjugate Production Sites and Area Served
6.2.2 Concortis Biotherapeutics Description, Business Overview and Total Revenue
6.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Concortis Biotherapeutics Products Offered
6.2.5 Concortis Biotherapeutics Recent Development
6.3 Sanofi
6.3.1 Sanofi Antibody-drug Conjugate Production Sites and Area Served
6.3.2 Sanofi Description, Business Overview and Total Revenue
6.3.3 Sanofi Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi Products Offered
6.3.5 Sanofi Recent Development
6.4 Celldex Therapeutics
6.4.1 Celldex Therapeutics Antibody-drug Conjugate Production Sites and Area Served
6.4.2 Celldex Therapeutics Description, Business Overview and Total Revenue
6.4.3 Celldex Therapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Celldex Therapeutics Products Offered
6.4.5 Celldex Therapeutics Recent Development
6.5 Synthon Holding BV
6.5.1 Synthon Holding BV Antibody-drug Conjugate Production Sites and Area Served
6.5.2 Synthon Holding BV Description, Business Overview and Total Revenue
6.5.3 Synthon Holding BV Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Synthon Holding BV Products Offered
6.5.5 Synthon Holding BV Recent Development
7 Antibody-drug Conjugate Manufacturing Cost Analysis
7.1 Antibody-drug Conjugate Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody-drug Conjugate
7.4 Antibody-drug Conjugate Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody-drug Conjugate Distributors List
8.3 Antibody-drug Conjugate Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Antibody-drug Conjugate Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody-drug Conjugate by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Antibody-drug Conjugate by Type (2021-2026)
10.2 Antibody-drug Conjugate Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody-drug Conjugate by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Antibody-drug Conjugate by Application (2021-2026)
10.3 Antibody-drug Conjugate Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody-drug Conjugate by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Antibody-drug Conjugate by Region (2021-2026)
10.4 North America Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.5 Europe Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.6 Asia Pacific Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.7 Latin America Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.8 Middle East and Africa Antibody-drug Conjugate Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antibody-drug Conjugate Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Antibody-drug Conjugate Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Antibody-drug Conjugate Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Antibody-drug Conjugate Manufacturers Covered in This Study
Table 5. Global Antibody-drug Conjugate Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Antibody-drug Conjugate Sales Share by Manufacturers (2015-2020)
Table 7. Global Antibody-drug Conjugate Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Antibody-drug Conjugate Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Antibody-drug Conjugate Sales Sites and Area Served
Table 11. Manufacturers Antibody-drug Conjugate Product Types
Table 12. Global Antibody-drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibody-drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugate as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Antibody-drug Conjugate Players
Table 16. Global Antibody-drug Conjugate Sales (K Units) by Region (2015-2020)
Table 17. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Table 18. Global Antibody-drug Conjugate Revenue (Million US$) by Region (2015-2020)
Table 19. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Table 20. North America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 21. North America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 22. North America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 24. Europe Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 25. Europe Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 26. Europe Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Antibody-drug Conjugate Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Antibody-drug Conjugate Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Table 32. Latin America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 33. Latin America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 34. Latin America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 40. Global Antibody-drug Conjugate Sales (K Units) by Type (2015-2020)
Table 41. Global Antibody-drug Conjugate Sales Share by Type (2015-2020)
Table 42. Global Antibody-drug Conjugate Revenue (Million US$) by Type (2015-2020)
Table 43. Global Antibody-drug Conjugate Revenue Share by Type (2015-2020)
Table 44. Global Antibody-drug Conjugate Price (USD/Unit) by Type (2015-2020)
Table 45. Global Antibody-drug Conjugate Sales (K Units) by Application (2015-2020)
Table 46. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 47. Global Antibody-drug Conjugate Sales Growth Rate by Application (2015-2020)
Table 48. Agensys Antibody-drug Conjugate Corporation Information
Table 49. Agensys Description and Business Overview
Table 50. Agensys Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Agensys Main Product
Table 52. Agensys Recent Development
Table 53. Concortis Biotherapeutics Antibody-drug Conjugate Corporation Information
Table 54. Concortis Biotherapeutics Corporation Information
Table 55. Concortis Biotherapeutics Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Concortis Biotherapeutics Main Product
Table 57. Concortis Biotherapeutics Recent Development
Table 58. Sanofi Antibody-drug Conjugate Corporation Information
Table 59. Sanofi Corporation Information
Table 60. Sanofi Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Sanofi Main Product
Table 62. Sanofi Recent Development
Table 63. Celldex Therapeutics Antibody-drug Conjugate Corporation Information
Table 64. Celldex Therapeutics Corporation Information
Table 65. Celldex Therapeutics Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Celldex Therapeutics Main Product
Table 67. Celldex Therapeutics Recent Development
Table 68. Synthon Holding BV Antibody-drug Conjugate Corporation Information
Table 69. Synthon Holding BV Corporation Information
Table 70. Synthon Holding BV Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Synthon Holding BV Main Product
Table 72. Synthon Holding BV Recent Development
Table 73. Sales Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Antibody-drug Conjugate Distributors List
Table 76. Antibody-drug Conjugate Customers List
Table 77. Market Key Trends
Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 79. Key Challenges
Table 80. Global Antibody-drug Conjugate Sales (K Units) Forecast by Type (2021-2026)
Table 81. Global Antibody-drug Conjugate Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Antibody-drug Conjugate Revenue (Million US$) Forecast by Type (2021-2026)
Table 83. Global Antibody-drug Conjugate Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 84. Global Antibody-drug Conjugate Sales (K Units) Forecast by Application (2021-2026)
Table 85. Global Antibody-drug Conjugate Revenue (Million US$) Forecast by Application (2021-2026)
Table 86. Global Antibody-drug Conjugate Sales (K Units) Forecast by Region (2021-2026)
Table 87. Global Antibody-drug Conjugate Sales Market Share Forecast by Region (2021-2026)
Table 88. Global Antibody-drug Conjugate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 89. Global Antibody-drug Conjugate Revenue Market Share Forecast by Region (2021-2026)
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Antibody-drug Conjugate
Figure 2. Global Antibody-drug Conjugate Sales Market Share by Type: 2020 VS 2026
Figure 3. Adcetris Product Picture
Figure 4. Kadcyla Product Picture
Figure 5. Global Antibody-drug Conjugate Consumption Market Share by Application: 2020 VS 2026
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Global Antibody-drug Conjugate Market Size 2015-2026 (US$ Million)
Figure 9. Global Antibody-drug Conjugate Sales Capacity (K Units) (2015-2026)
Figure 10. Global Antibody-drug Conjugate Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Antibody-drug Conjugate Sales Share by Manufacturers in 2020
Figure 12. Global Antibody-drug Conjugate Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Antibody-drug Conjugate Revenue in 2019
Figure 14. Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Figure 16. Global Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 17. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Figure 18. Global Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 19. North America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 20. North America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 21. U.S. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 26. Europe Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 27. Germany Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 38. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 39. China Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 62. Latin America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 63. Mexico Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 71. Turkey Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Antibody-drug Conjugate by Type (2015-2020)
Figure 78. Sales Market Share of Antibody-drug Conjugate by Type in 2019
Figure 79. Revenue Share of Antibody-drug Conjugate by Type (2015-2020)
Figure 80. Revenue Market Share of Antibody-drug Conjugate by Type in 2019
Figure 81. Global Antibody-drug Conjugate Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Figure 83. Global Antibody-drug Conjugate Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Antibody-drug Conjugate by Application (2015-2020)
Figure 85. Global Revenue Share of Antibody-drug Conjugate by Application in 2020
Figure 86. Agensys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Concortis Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Celldex Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Synthon Holding BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Price Trend of Key Raw Materials
Figure 92. Manufacturing Cost Structure of Antibody-drug Conjugate
Figure 93. Manufacturing Process Analysis of Antibody-drug Conjugate
Figure 94. Antibody-drug Conjugate Industrial Chain Analysis
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Porter's Five Forces Analysis
Figure 98. North America Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 99. North America Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 100. Europe Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 101. Europe Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Latin America Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 103. Latin America Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Middle East and Africa Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. Middle East and Africa Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Asia Pacific Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Asia Pacific Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
  • Global Hematological Malignancies Disease Market Size, Status and Forecast 2020-2026
    Published: 03-Apr-2020        Price: US 3900 Onwards        Pages: 134
    This report focuses on the global Hematological Malignancies Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hematological Malignancies Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Affymetrix - SkylineDx - AgenaBio - Signal Genetics - Cancer Genetics Inc - Illumin......
  • Global Bicalutamide Market Growth 2020-2025
    Published: 02-Apr-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Bicalutamide market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bicalutamide business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Bicalutamide market by type, application, key ma......
  • 2015-2027 Global 5-Fluorouracil Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 31-Mar-2020        Price: US 3460 Onwards        Pages: 138
    The worldwide market for 5-Fluorouracil is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving fac......
  • 2014-2029 Report on Global Cancer Treatment Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 31-Mar-2020        Price: US 2500 Onwards        Pages: 133
    The global Cancer Treatment Drugs market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Cancer Treatment Drugs from 2014-2019, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, histor......
  • Global Prostate Cancer Drugs Market Research Report 2020
    Published: 31-Mar-2020        Price: US 2900 Onwards        Pages: 138
    The global Prostate Cancer Drugs market is valued at US$ 6080 million in 2020 is expected to reach US$ 9481.8 million by the end of 2026, growing at a CAGR of 6.5% during 2021-2026. This report focuses on Prostate Cancer Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Prostate Cancer Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on s......
  • 2014-2029 Report on Global Docetaxel Market by Player, Region, Type, Application and Sales Channel
    Published: 31-Mar-2020        Price: US 2500 Onwards        Pages: 103
    The global Docetaxel market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Docetaxel from 2014-2019, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future per......
  • 2015-2027 Global Cyclophosphamide Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 31-Mar-2020        Price: US 3460 Onwards        Pages: 116
    The worldwide market for Cyclophosphamide is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving f......
  • 2015-2027 Global Temozolomide Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 31-Mar-2020        Price: US 3460 Onwards        Pages: 135
    The worldwide market for Temozolomide is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving facto......
  • Global Paclitaxel Injection Market Research Report 2015-2025
    Published: 30-Mar-2020        Price: US 1970 Onwards        Pages: 84
    Summary The global Paclitaxel Injection market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs